CytoMed Therapeutics (GDTC) vs Phio Pharmaceuticals (PHIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CytoMed Therapeutics (GDTC) has outperformed Phio Pharmaceuticals (PHIO) over the past year, losing 54.6% versus a loss of 57.5%. CytoMed Therapeutics is the larger company by market cap ($11.7 million vs $11.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GDTC | PHIO |
|---|---|---|
| Share price | $0.98 | $0.9995 |
| Market cap | $11.70M | $11.61M |
| 1-day change | +5.40% | +0.51% |
| YTD return | -26.59% | -4.81% |
| 1-year return | -54.63% | -57.47% |
| 5-year return | — | -99.45% |
| EPS (TTM) | $-0.23 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.68 | $4.19 |
| 52-week low | $0.68 | $0.813 |
| Distance from 52-week high | -73.37% | -76.15% |
| Average volume | 78.41K | 584.05K |
| Shares outstanding | 11.93M | 11.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GDTC vs PHIO FAQ
Which is bigger, CytoMed Therapeutics or Phio Pharmaceuticals?
CytoMed Therapeutics (GDTC) is larger, with a market capitalization of $11.70M compared with $11.61M for Phio Pharmaceuticals (PHIO).
Which stock has performed better over the past year, GDTC or PHIO?
GDTC returned -54.63% over the past 12 months, compared with -57.47% for PHIO (price return, excluding dividends). Past performance does not predict future results.
Are CytoMed Therapeutics and Phio Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.